Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Phase I/II, Open-Label, Dose-Finding Pilot Study of the Combination of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

NCT01464034 is registered in ClinicalTrials.gov with Criterium, Inc. as lead sponsor.

NCT NCT01464034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01464034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Phase I/II, Open-Label, Dose-Finding Pilot Study of the Combination of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Lead sponsor
Criterium, Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
November 30, 2011
Completion date
July 31, 2020
Enrollment
136 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma